Figure 1From: Cetuximab and radiation for primary and recurrent squamous cell carcinoma of the head and neck (SCCHN) in the elderly and multi-morbid patient: a single-centre experienceLocoregional PFS, all pts (n = 69); Mean 25.6 months, 95% CI: 20.4 - 30.8 months.Back to article page